This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210106005697\/en\/<\/a><\/p>\n \nIn the next few months, billions of doses of COVID-19 vaccines will need to be rapidly and safely administered to people around the world. The complexity of cold chain conditions, the timeliness of delivery as well as the need to mitigate risk of any deviation are identified as critical challenges for successful large-scale vaccination.\n<\/p>\n \nV-TRACE is an integrated solution designed to track and trace COVID-19 vaccines, while ensuring risk mitigation thanks to controls and inspections all along the logistics chain. V-TRACE provides a global control of the supply chain thanks to the local presence of inspectors in the field.\n<\/p>\n Didier Michaud-Daniel, CEO, Bureau Veritas, commented:<\/b><\/p>\n \u201cThe priority for all governments and private institutions is to ensure that vaccine doses are safe and secure. This means tracking and tracing vaccines along the supply chain. Bureau Veritas\u2019 experience in independent inspections along the supply chain to control inventories, storage and logistics conditions complements OPTEL\u2019s ability to provide real-time traceability information. By combining our respective expertise, we are able to provide a single solution to control and mitigate risk throughout the logistics chains. Building on almost 200 years of expertise in shaping trust between companies, governments and society at large, Bureau Veritas is proud to partner with OPTEL to ensure the health and safety of people around the world<\/i>.\u201d<\/i><\/p>\n Louis Roy, Founder and CEO, OPTEL Group, added:<\/b><\/p>\n \u201c<\/i>The COVID-19 vaccine distribution is an unprecedented challenge for nations across the world. To successfully address this challenge, nations will need transparency at every level of the supply chain. This is precisely what OPTEL\u2019s traceability platform has been built for, over the last three decades. OPTEL is proud to be joining forces with Bureau Veritas to bring complete visibility and certainty to the distribution of vaccines. As the leader in digital traceability, our mission is to use our technologies to create a better world. We know our traceability technologies combined with the expertise of Bureau Veritas can make a difference to overcome this historical challenge.<\/i>\u201d<\/i><\/p>\n \nThanks to this partnership, OPTEL and Bureau Veritas are able to offer a combined expertise that is unrivalled in the pharmaceutical industry and in supply chain assurance.\n<\/p>\n \nV-TRACE is a unique integrated solution providing Governments with:\n<\/p>\n About OPTEL Group \nOPTEL is the only company with the ability to offer true end-to-end traceability, providing actionable, granular data at every step of the supply chain\u2014from raw materials to the consumer and beyond.\n<\/p>\n \nFounded in 1989, OPTEL is a Certified B Corporation headquartered in Canada, with facilities in India, Ireland and Brazil, as well as employees worldwide.<\/p>\n \nWith more than 30 years of expertise and experience in the pharmaceutical supply chain, OPTEL is working with the world leading brands and tracking 15B items per year.\n<\/p>\n \nFor more information, visit www.optelgroup.com<\/a>.\n<\/p>\n About Bureau Veritas \nBureau Veritas is also a global leader in supply chain assurance and COVID-19 hygiene protocol audits: with 70+ accreditations, 145,000+ certificates, a presence in 140+ countries, and recognized experience with governments, the group has supported its clients in the restart of their activities post COVID-19 lockdowns.\n<\/p>\n \nBureau Veritas is listed on Euronext Paris and belongs to the Next 20 index.\n<\/p>\n \nCompartment A, ISIN code FR 0006174348, stock symbol: BVI.\n<\/p>\n \nFor more information, visit www.bureauveritas.com<\/a>, and follow us on Twitter<\/a> (@bureauveritas) and LinkedIn<\/a>.\n<\/p>\n\n
\n
<\/b>OPTEL is a leading global provider of traceability systems whose goal is to use its innovative technologies to build a better world through the Intelligent Supply Chain\u00ae.\n<\/p>\n
\n
<\/b>Bureau Veritas is a world leader in laboratory testing, inspection and certification services. Created in 1828, the Group has more than 75,000 employees located in more than 1,500 offices and laboratories around the globe. Bureau Veritas helps its clients improve their performance by offering services and innovative solutions in order to ensure that their assets, products, infrastructure and processes meet standards and regulations in terms of quality, health and safety, environmental protection and social responsibility.\n<\/p>\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20210106005697\/en\/850538\/3\/Logo_CMYK_highres.jpg\"){kind=logo}
<\/td>\n<\/tr>\n![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20210106005697\/en\/850587\/3\/OPTEL+%28002%29.jpg\")
<\/td>\n<\/tr>\n